Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-018-2185-1.

Title:
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter | Cancer Immunology, Immunotherapy
Description:
Tumor relapse and metastatic spreading act as major hindrances to achieve complete cure of breast cancer. Evidence suggests that cancer stem cells (CSC) would function as a reservoir for the local and distant recurrence of the disease, due to their resistance to radio- and chemotherapy and their ability to regenerate the tumor. Therefore, the identification of appropriate molecular targets expressed by CSC may be critical in the development of more effective therapies. Our studies focused on the identification of mammary CSC antigens and on the development of CSC-targeting vaccines. We compared the transcriptional profile of CSC-enriched tumorspheres from an Her2+ breast cancer cell line with that of the more differentiated parental cells. Among the molecules strongly upregulated in tumorspheres we selected the transmembrane amino-acid antiporter xCT. In this review, we summarize the results we obtained with different xCT-targeting vaccines. We show that, despite xCT being a self-antigen, vaccination was able to induce a humoral immune response that delayed primary tumor growth and strongly impaired pulmonary metastasis formation in mice challenged with tumorsphere-derived cells. Moreover, immunotargeting of xCT was able to increase CSC chemosensitivity to doxorubicin, suggesting that it may act as an adjuvant to chemotherapy. In conclusion, our approach based on the comparison of the transcriptome of tumorspheres and parental cells allowed us to identify a novel CSC-related target and to develop preclinical therapeutic approaches able to impact on CSC biology, and therefore, hampering tumor growth and dissemination.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

pubmed, article, google, scholar, cancer, cas, cells, central, stem, cell, breast, mice, cavallo, federica, xct, conti, cystineglutamate, vaccines, vaccination, res, ruiu, tumor, httpsdoiorg, mammary, access, dna, sato, immunotherapy, rolih, bolli, quaglino, csc, molecular, therapeutic, httpsdoiorgcan, immunol, lanzardo, system, privacy, cookies, content, research, antiporter, roberto, donofrio, laura, particles, biol, forni, vaccine,

Topics {✒️}

oxidative-stress-inducing agent paraquat month download article/chapter cystine/glutamate transporter-deficient mice tumorsphere-derived cells cancer stem cells–perspectives cystine/glutamate exchange transporter mrna-transfected dendritic cells xct cystine–glutamate antiporter stem/progenitor cell properties impaired long-term potentiation caveolin-1/beta-catenin pathway long-term memory deficits cancer stem cells article cancer immunology cystine-glutamate transporter slc7a11 cystine/glutamate antiporter system cancer stem cell xct-deficient sut mice inhibit mammary carcinogenesis gene delivery vector full article pdf cystine/glutamate transporter csc-related target xct-targeting vaccines laura conti produced tumor-initiating cells differentiated parental cells parental cells allowed cystine-glutamate exchanger balb-neut transgenic mice molecular targets expressed effective therapies privacy choices/manage cookies related subjects xct-dependent manner bohv-4-based vector cancer vaccine development csc-targeting vaccines lollini pl mammary csc antigens gene ther 8 humoral immune response immune checkpoint inhibitors reactive oxygen species 6-hydroxydopamine-induced toxicity xct-deficient mice cancer immunotherapy immune-targeting neuronal cell death cancer stem

Questions {❓}

  • Galadari S, Rahman A, Pallichankandy S, Thayyullathil F (2017) Reactive oxygen species and cancer paradox: To promote or to suppress?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
         description:Tumor relapse and metastatic spreading act as major hindrances to achieve complete cure of breast cancer. Evidence suggests that cancer stem cells (CSC) would function as a reservoir for the local and distant recurrence of the disease, due to their resistance to radio- and chemotherapy and their ability to regenerate the tumor. Therefore, the identification of appropriate molecular targets expressed by CSC may be critical in the development of more effective therapies. Our studies focused on the identification of mammary CSC antigens and on the development of CSC-targeting vaccines. We compared the transcriptional profile of CSC-enriched tumorspheres from an Her2+ breast cancer cell line with that of the more differentiated parental cells. Among the molecules strongly upregulated in tumorspheres we selected the transmembrane amino-acid antiporter xCT. In this review, we summarize the results we obtained with different xCT-targeting vaccines. We show that, despite xCT being a self-antigen, vaccination was able to induce a humoral immune response that delayed primary tumor growth and strongly impaired pulmonary metastasis formation in mice challenged with tumorsphere-derived cells. Moreover, immunotargeting of xCT was able to increase CSC chemosensitivity to doxorubicin, suggesting that it may act as an adjuvant to chemotherapy. In conclusion, our approach based on the comparison of the transcriptome of tumorspheres and parental cells allowed us to identify a novel CSC-related target and to develop preclinical therapeutic approaches able to impact on CSC biology, and therefore, hampering tumor growth and dissemination.
         datePublished:2018-06-15T00:00:00Z
         dateModified:2018-06-15T00:00:00Z
         pageStart:131
         pageEnd:141
         sameAs:https://doi.org/10.1007/s00262-018-2185-1
         keywords:
            Cancer stem cell
            Vaccine
            Tumorsphere
            xCT
            Breast cancer
            NIBIT 2017
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-018-2185-1/MediaObjects/262_2018_2185_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-018-2185-1/MediaObjects/262_2018_2185_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-018-2185-1/MediaObjects/262_2018_2185_Fig3_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:68
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Roberto Ruiu
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Valeria Rolih
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elisabetta Bolli
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giuseppina Barutello
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Federica Riccardo
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elena Quaglino
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Irene Fiore Merighi
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Federica Pericle
               affiliation:
                     name:Agilvax, Inc
                     address:
                        name:Agilvax, Inc, Albuquerque, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gaetano Donofrio
               affiliation:
                     name:University of Parma
                     address:
                        name:Department of Medical Veterinary Science, University of Parma, Parma, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Federica Cavallo
               url:http://orcid.org/0000-0003-4571-1060
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laura Conti
               affiliation:
                     name:University of Turin
                     address:
                        name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
      description:Tumor relapse and metastatic spreading act as major hindrances to achieve complete cure of breast cancer. Evidence suggests that cancer stem cells (CSC) would function as a reservoir for the local and distant recurrence of the disease, due to their resistance to radio- and chemotherapy and their ability to regenerate the tumor. Therefore, the identification of appropriate molecular targets expressed by CSC may be critical in the development of more effective therapies. Our studies focused on the identification of mammary CSC antigens and on the development of CSC-targeting vaccines. We compared the transcriptional profile of CSC-enriched tumorspheres from an Her2+ breast cancer cell line with that of the more differentiated parental cells. Among the molecules strongly upregulated in tumorspheres we selected the transmembrane amino-acid antiporter xCT. In this review, we summarize the results we obtained with different xCT-targeting vaccines. We show that, despite xCT being a self-antigen, vaccination was able to induce a humoral immune response that delayed primary tumor growth and strongly impaired pulmonary metastasis formation in mice challenged with tumorsphere-derived cells. Moreover, immunotargeting of xCT was able to increase CSC chemosensitivity to doxorubicin, suggesting that it may act as an adjuvant to chemotherapy. In conclusion, our approach based on the comparison of the transcriptome of tumorspheres and parental cells allowed us to identify a novel CSC-related target and to develop preclinical therapeutic approaches able to impact on CSC biology, and therefore, hampering tumor growth and dissemination.
      datePublished:2018-06-15T00:00:00Z
      dateModified:2018-06-15T00:00:00Z
      pageStart:131
      pageEnd:141
      sameAs:https://doi.org/10.1007/s00262-018-2185-1
      keywords:
         Cancer stem cell
         Vaccine
         Tumorsphere
         xCT
         Breast cancer
         NIBIT 2017
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-018-2185-1/MediaObjects/262_2018_2185_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-018-2185-1/MediaObjects/262_2018_2185_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-018-2185-1/MediaObjects/262_2018_2185_Fig3_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:68
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Roberto Ruiu
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Valeria Rolih
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elisabetta Bolli
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giuseppina Barutello
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Federica Riccardo
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elena Quaglino
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Irene Fiore Merighi
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Federica Pericle
            affiliation:
                  name:Agilvax, Inc
                  address:
                     name:Agilvax, Inc, Albuquerque, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gaetano Donofrio
            affiliation:
                  name:University of Parma
                  address:
                     name:Department of Medical Veterinary Science, University of Parma, Parma, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Federica Cavallo
            url:http://orcid.org/0000-0003-4571-1060
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laura Conti
            affiliation:
                  name:University of Turin
                  address:
                     name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:68
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
      name:Agilvax, Inc
      address:
         name:Agilvax, Inc, Albuquerque, USA
         type:PostalAddress
      name:University of Parma
      address:
         name:Department of Medical Veterinary Science, University of Parma, Parma, Italy
         type:PostalAddress
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
      name:University of Turin
      address:
         name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Roberto Ruiu
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
      name:Valeria Rolih
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
      name:Elisabetta Bolli
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
      name:Giuseppina Barutello
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
      name:Federica Riccardo
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
      name:Elena Quaglino
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
      name:Irene Fiore Merighi
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
      name:Federica Pericle
      affiliation:
            name:Agilvax, Inc
            address:
               name:Agilvax, Inc, Albuquerque, USA
               type:PostalAddress
            type:Organization
      name:Gaetano Donofrio
      affiliation:
            name:University of Parma
            address:
               name:Department of Medical Veterinary Science, University of Parma, Parma, Italy
               type:PostalAddress
            type:Organization
      name:Federica Cavallo
      url:http://orcid.org/0000-0003-4571-1060
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
      name:Laura Conti
      affiliation:
            name:University of Turin
            address:
               name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
      name:Agilvax, Inc, Albuquerque, USA
      name:Department of Medical Veterinary Science, University of Parma, Parma, Italy
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
      name:Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(294)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.23s.